Fiche publication
Date publication
février 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin
,
Pr LANG Hervé
,
Pr NAMER Izzie-Jacques
Tous les auteurs :
Imperiale A, Cabral JF, Rust E, Flores-Turk G, Renard C, Hubele F, Detour J, Lang H, Gangi A, Namer IJ
Lien Pubmed
Résumé
The understanding of radiotracer's physiological biodistribution as well as the potential source of false-positive results is crucial for an accurate diagnostic interpretation of (18)F-fluorocholine PET/CT examination in patients with prostate cancer. We illustrate the results of whole-body (18)F-fluorocholine PET/CT in a 79-year-old man with biochemical suspicion of prostate adenocarcinoma relapse. PET/CT study showed a focally increased (18)F-fluorocholine uptake, characterizing an incidentally found adrenocortical adenoma. Finally, we draw oncologists' attention to the possible false-positive results of (18)F-fluorocholine PET related to benign and unsuspected adrenocortical lesions in patients with a history of prostate malignancy.
Référence
Clin Nucl Med. 2013 Feb;38(2):e83-4